Find the product you need

News

InVivoMab anti-mouse CD40

Catalog number: BE0016-2_100mg
Brand: Bio X Cell
Packing: 100 mg
Other sizes: Other sizes available
Price: € 3131.00
Expected delivery time: 7 days
Quantity:
Spin UpSpin Down

Product specifications for - InVivoMab anti-mouse CD40

Promotion: 
Promotion: The price displayed is only for academic or non-profit organizations. Please contact our helpdesk for regular prices.
Overview: 
Product group: Antibodies
Category: Primary Antibodies
Application: Other Application
Host: Rat
Clonality: Monoclonal
Isotype: IgG2a
Properties: 
Molecular weight: 150 kDa
Datasheet: Datasheet
  Research Use Only
UNSPSC: 12352203
Concentration: 2-10 mg/ml
Scientific information: 
Clone ID: FGK4.5/FGK45
Related products: 
Related products: Recommended Isotype Control(s): InVivoMab rat IgG2a isotype control (BE0089)
Recommended Dilution Buffer: InVivoPure pH 7.0 Dilution Buffer (IP0070)
Additional information: 
Synonyms: FGK4.5/FGK45; BE0016-2; CD40; p50; TNFRSF5; CDW40; Bp50; tumor necrosis factor receptor superfamily, member 5; tumor necrosis factor receptor superfamily member 5; nerve growth factor receptor-related B-lymphocyte activation molecule; CD40L receptor; CD40 type II isoform; CD40 antigen (TNF receptor superfamily member 5); B-cell surface antigen CD40; B cell-associated molecule; B cell surface antigen CD40; CD40 molecule, TNF receptor superfamily member 5; BioXCell
Xu H, Chaudhri VK, Wu Z, et al. Regulation of bifurcating B cell trajectories by mutual antagonism between transcription factors IRF4 and IRF8. Nat Immunol. 2015;16(12):1274-81. Read more
Bartkowiak T, Singh S, Yang G, et al. Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine. Proc Natl Acad Sci USA. 2015;112(38):E5290-9. Read more
Conde P, Rodriguez M, Van der touw W, et al. DC-SIGN(+) Macrophages Control the Induction of Transplantation Tolerance. Immunity. 2015;42(6):1143-58. Read more
Carmi Y, Spitzer MH, Linde IL, et al. Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity. Nature. 2015;521(7550):99-104. Read more
Erickson JJ, Rogers MC, Hastings AK, Tollefson SJ, Williams JV. Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection. J Immunol. 2014;193(10):5108-17. Read more
Muppidi JR, Schmitz R, Green JA, et al. Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma. Nature. 2014;516(7530):254-8. Read more
Sandin LC, Orlova A, Gustafsson E, et al. Locally delivered CD40 agonist antibody accumulates in secondary lymphoid organs and eradicates experimental disseminated bladder cancer. Cancer Immunol Res. 2014;2(1):80-90. Read more
Rabenstein H, Behrendt AC, Ellwart JW, et al. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells. J Immunol. 2014;192(8):3507-17. Read more
Hailemichael Y, Dai Z, Jaffarzad N, et al. Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion. Nat Med. 2013;19(4):465-72. Read more
Locatelli G, Wörtge S, Buch T, et al. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat Neurosci. 2012;15(4):543-50. Read more
See All